Frequently Asked Questions for Healthcare Professionals.

HCP Connect is an institutional clinical intelligence registry built for US-licensed healthcare professionals. It provides FDA drug records, peer-reviewed drug update articles, NPI provider lookup, and specialty clinical coverage in one authenticated platform. It is operated by Stravent LLC and is independent of pharmaceutical companies and government bodies.

All clinical articles on HCP Connect are authored by US-licensed healthcare professionals including physicians, pharmacists, and clinical specialists. Each article displays the author's name and credentials. Editorial decisions are made independently of advertisers, pharmaceutical companies, and commercial partners.

No. HCP Connect is independently operated by Stravent LLC and has no affiliation with any pharmaceutical manufacturer, government health agency, or medical society. Advertisers and commercial sponsors have no influence over editorial content, clinical conclusions, or drug data presented on the platform.

HCP Connect is privately funded by Stravent LLC. The platform may display clearly labelled advertising from approved partners. Funding sources have no influence over clinical content, editorial decisions, or the drug data presented. Full funding and independence disclosures are available on the Transparency page.

All drug update articles are authored by licensed clinicians and referenced to primary sources including FDA label records, peer-reviewed journals, WHO guidelines, and CDC publications. Content is reviewed by qualified healthcare professionals before publication. Factual corrections are publicly logged in the corrections record.

Drug update articles are written by specialist clinicians and reviewed by qualified healthcare professionals before publication. Each article displays the author name, credentials, published date, and last reviewed date. The editorial team ensures content is clinically accurate and referenced to verified primary sources.

To report a factual error, email the editorial team at [email protected] with the article URL and the specific correction. All validated corrections are publicly documented in the HCP Connect corrections log. We aim to review and resolve all reported errors within 48 hours.

No. HCP Connect is not approved, endorsed, or affiliated with the US Food and Drug Administration (FDA). The platform sources drug data from official FDA label records (the FAERS and DailyMed databases) but operates independently. Always consult official FDA labelling and clinical judgement for prescribing decisions.

HCP Connect sources drug data from official FDA label records, including the National Drug Code (NDC) directory and DailyMed database. All drug monographs display the source reference and last updated date. Provider lookup data is sourced from the NPPES national registry maintained by the Centers for Medicare and Medicaid Services.

The drug database is updated continuously from FDA label records. Each drug monograph displays a last updated timestamp. Drug update articles covering FDA approvals, label changes, and safety alerts are published as soon as updates are confirmed from primary FDA sources. Always verify against the current FDA prescribing information for clinical use.

HCP Connect is intended as a clinical reference tool to support informed decision-making. It should not be used as a substitute for the current FDA-approved prescribing information, clinical guidelines, or professional judgement. Always consult the full prescribing information and your clinical training when making prescribing decisions.

An NDC (National Drug Code) is a unique 10 or 11-digit identifier assigned to every drug product registered with the FDA. On HCP Connect, you can search for a drug by its NDC number directly in the Drug Index search bar. NDC records include the drug name, manufacturer, dosage form, strength, and FDA label data.

Yes. HCP Connect includes a drug interaction review tool accessible from the Drug Index. The tool uses FDA label data to identify known drug-drug interactions and provides clinically relevant context. For comprehensive interaction screening, always supplement with current prescribing information and institutional pharmacy resources.

The dosage calculator is accessible from the Drug Index under Reference Modules. Select a drug, enter patient weight and clinical parameters, and the tool provides dosage references based on FDA label data. Results are reference values only - always verify against current prescribing information and apply clinical judgement.

A drug monograph is a structured clinical document summarising a drug's approved uses, dosage forms, administration routes, contraindications, drug interactions, warnings, and prescribing information. On HCP Connect, each drug monograph is sourced from official FDA label records and includes the NDC number, manufacturer, and last updated date.

The HCP Connect drug database contains over 130,000 FDA-registered drug records sourced from the National Drug Code directory. Records include prescription drugs, generic equivalents, OTC medications, and biologics. The database is continuously updated as new drugs receive FDA registration or existing records are updated.

The pill identifier tool on HCP Connect allows clinicians to identify unknown medications by physical characteristics including shape, colour, imprint code, and dosage form. Results are matched against FDA NDC records and display the drug name, manufacturer, strength, and prescribing context. Access it from the Drug Index under Reference Modules.

An NPI (National Provider Identifier) is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). It is required for billing Medicare and Medicaid and is used to identify providers in all HIPAA-covered transactions. Every licensed US healthcare professional has an NPI.

On HCP Connect, enter the provider's name, state, or specialty in the NPI lookup tool to search the NPPES national registry. You can also search directly by NPI number if known. Results display the provider's legal name, NPI, taxonomy code, practice address, and registration status. The NPPES registry is the official CMS-maintained source for all US provider NPI data.

Yes. HCP Connect's NPI lookup tool queries the NPPES (National Plan and Provider Enumeration System) registry, which is the official CMS-maintained database of all US healthcare provider NPI numbers. The data is sourced directly from NPPES and reflects the same provider records available at the official CMS NPI registry.

To access account-level tools on HCP Connect, create an account and submit your NPI number for verification. Our team cross-references your NPI against NPPES registry records to confirm your active US provider status. Verification typically completes within 24 hours. Once verified, you receive a Verified HCP badge and access to account-level clinical tools.

NPI verification on HCP Connect typically completes within 24 hours of submission. Our team reviews your NPI against active NPPES registry records during business hours. You will receive a confirmation notification once your credentials are verified and your account is upgraded to Verified HCP status.

Verified HCPs on HCP Connect gain access to account-level tools including saved reading lists, drug alert subscriptions by specialty, personalised drug update feeds, and additional clinical reference features. Public pages including the drug index, NPI lookup, and drug update articles remain fully accessible without verification.

Drug Updates are peer-reviewed clinical summaries authored by US-licensed physicians and specialists covering FDA drug approvals, black box warning changes, new indications, dosage updates, biosimilar launches, and drug interaction alerts. Each article includes key clinical data, prescriber implications, and references to primary FDA and journal sources.

HCP Connect publishes new drug update articles daily. Coverage prioritises FDA approval decisions, label changes, black box warning updates, and clinical guideline revisions as they are announced. Articles are published within 24 to 48 hours of a confirmed FDA or regulatory update.

Yes. FDA drug approval coverage is the primary focus of HCP Connect Drug Updates. Every new drug approval, supplemental approval, accelerated approval, and breakthrough therapy designation is covered with a structured clinical summary including the approved indication, trial data, prescriber implications, and FDA label reference.

Yes. Black box warning additions and revisions are covered as priority updates on HCP Connect. These are published as urgent drug updates with structured clinical summaries including the affected drug, the nature of the warning, affected patient populations, and prescriber action guidance. Black box warning updates are prioritised for same-day publication.

On the Drug Updates page, use the specialty filter to view updates for Cardiology, Oncology, Neurology, Endocrinology, Pharmacology, Pulmonology, Gastroenterology, Psychiatry, and other specialties. You can also use the quick-select specialty pills on the homepage to go directly to your specialty feed.

Yes. Verified HCPs on HCP Connect can subscribe to specialty-filtered drug update briefings delivered by email. Select your specialty during account setup or from your profile settings and receive a curated weekly digest of approvals, safety alerts, and clinical updates relevant to your practice area.

HCP Connect Drug Updates cover 30 or more medical specialties including Cardiology, Oncology, Neurology, Endocrinology, Pulmonology, Gastroenterology, Psychiatry, Dermatology, Hematology, Infectious Disease, Pharmacology, Otolaryngology, and Biomedical Research. Specialty coverage expands as new drug approvals and clinical updates are published.

HCP Connect is designed for US-licensed healthcare professionals including physicians (MD and DO), nurse practitioners, physician assistants, pharmacists, registered nurses, clinical specialists, and healthcare administrators. Public pages are accessible to all users for research purposes. Account-level tools require NPI-based credential verification.

Yes. Public pages on HCP Connect including the drug index, drug update articles, NPI lookup, and author directory are free to access without registration. Account-level features including saved reading lists, drug alert subscriptions, and personalised specialty feeds require a free account with NPI verification.

No. The HCP Connect drug index, drug monographs, NPI lookup, and drug update articles are publicly accessible without creating an account. An account is only required to access personalised features such as saved articles, specialty alert subscriptions, and account-level clinical tools.

HCP Connect is designed primarily for US-licensed healthcare professionals and the drug data is sourced from US FDA label records. International users may access public pages for research purposes, but drug information reflects US prescribing standards and may differ from local regulatory approvals and dosing guidelines in other countries.

Yes. HCP Connect does not sell or share personal data with pharmaceutical companies, advertisers, or third parties. NPI verification data is used solely for credential confirmation and is not used for commercial targeting. Full details of data handling practices are available in the HCP Connect Privacy Policy.

HCP Connect combines FDA drug records, NPI provider lookup, peer-reviewed drug update articles, specialty filtering, and drug interaction tools in a single authenticated platform built exclusively for US-licensed clinicians. Unlike general health sites, all content is authored by licensed healthcare professionals and referenced to FDA or peer-reviewed sources. The platform is independently operated with full editorial independence from pharmaceutical manufacturers.

Drug update articles on HCP Connect are authored by licensed healthcare professionals and reviewed by qualified clinical specialists before publication. Content is referenced to peer-reviewed journals, FDA label records, WHO guidelines, and CDC publications. HCP Connect follows an editorial independence policy that separates clinical content from commercial relationships.

HCP Connect drug update articles are intended as clinical reference summaries and cite primary sources including FDA label data, peer-reviewed journals, and regulatory agency publications. For formal clinical documentation, citing the primary source referenced in the article is recommended. Each article includes a references section with primary source links for this purpose.

HCP Connect drug update articles are referenced to FDA drug approval announcements and label records, peer-reviewed clinical trial data published in journals including NEJM, JAMA, Lancet, and BMJ, WHO and CDC clinical guidelines, and NPPES provider registry data. All sources are cited within each article and available for direct verification.

When a factual error is identified in a published article, HCP Connect issues a correction notice on the article page, updates the content, and logs the correction with the date and nature of the change in the public corrections log. Corrections can be submitted by any reader via the editorial contact page.

Yes. HCP Connect follows a published editorial independence policy that separates clinical content from commercial relationships. Content is required to be authored by licensed clinicians, referenced to primary sources, and reviewed before publication. The platform's editorial standards, funding disclosures, and corrections process are all publicly documented on the Transparency and Editorial Policy pages.